Fortis Healthcare Limited is set to acquire Jalandhar’s Shrimann Superspeciality Hospital for $53 million, aiming to enhance its operational capacity and service offerings in Punjab.
Information on the Target
Fortis Healthcare Limited is poised to acquire Shrimann Superspeciality Hospital, a multi-specialty hospital located in Jalandhar, Punjab, for approximately $53 million (INR 462 crores) through a slump sale. This acquisition encompasses the entire business operations, the hospital building, land, and an additional land parcel for potential future expansion. Shrimann Hospital currently operates with a capacity of 228 beds, of which 191 are actively in use.
Established in 2018, Shrimann Superspeciality Hospital is accredited by the National Accreditation Board for Hospitals & Healthcare Providers (NABH) and provides essential medical services in key specialties such as Cardiac Sciences, Nephrology, General and Laparoscopic Surgery, Neuro Sciences, Oncology, and Gastroenterology. For the fiscal year 2024-25, the hospital is anticipated to generate revenue of INR 154 crores with an EBITDA of INR 36 crores.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Punjab
The healthcare sector in Punjab has been witnessing significant growth, driven by increasing population and rising demand for quality healthcare services. The state government has also been investing
Similar Deals
Alkem Laboratories Ltd → Adroit Biomed Ltd and Bombay Ortho Industries Pvt Ltd
2025
Torrent Pharmaceuticals → JB Chemicals and Pharmaceuticals
2025
Metropolis Healthcare Limited → Core Diagnostics Private Limited
2024
Asahi Songwon Colors Limited → Atlas Life Sciences Pvt. Ltd.
2022
PharmEasy → Medlife International Private Limited
2021
Fortis Healthcare Limited
invested in
Shrimann Superspeciality Hospital
in 2025
in a Merger deal
Disclosed details
Transaction Size: $53M
Revenue: $19M
EBITDA: $4M